Singapore: China-based research and development service provider, WuXi PharmaTech, plans to expand its operations in US by opening offices in Boston and San Francisco by early 2015.

The company has established facilities in St Paul, Philadelphia, Atlanta, Plainsboro (NJ), and San Diego. In October 2014, WuXi opened an office in Israel to tap into biotech opportunities there.

"Our vision is to enable anyone and any company to discover and develop healthcare products to benefit the world's patients," said Dr Ge Li, chairman and CEO, WuXi PharmaTech. "These new offices bring our comprehensive platform of integrated R&D services closer to where entrepreneurs are and where cutting-edge science is being done."